NPL and cancer: In summary, the pan-cancer analysis revealed that comutation of Spliceosome (Sp) pathways and the Hedgehog (He) signaling pathway (defined as SpHe-comut+) was associated with increased TMB and NAL levels, as well as increased levels of immune-related signatures.